Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Robert Liptak currently holds 4,332,775 shares of Ophthotech Corp. (OPHT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Robert Liptak has been a net seller of OPHT stock. They have purchased $17.0M and sold $21.8M worth of shares.
Robert Liptak's most recent insider trade was on Jan 28, 2016, when they sold 32,521 shares at $0.26 per share.
Robert Liptak serves as Executive at Ophthotech Corp. (OPHT). They have executed 31 insider transactions totaling $38.8M over their tenure at the company.
Robert Liptak holds the position of Executive at Ophthotech Corp., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 16 years and currently hold a stake valued at $0.
Robert Liptak has shown a selling trading pattern, with $17.0M in total purchases and $21.8M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Robert Liptak was on Dec 17, 2013, when they purchased $10.0M worth of TLOG shares. This transaction involved 1,425,063 shares at $7.00 per share.
Robert Liptak currently owns 4,332,775 shares of Ophthotech Corp. (OPHT), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Robert Liptak's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Robert Liptak has 31 Form 4 filings on record as an insider at Ophthotech Corp..
Set alerts for Robert Liptak and 40,000+ other insiders.